VEON (NASDAQ:VEON) Raised to C- at TheStreet

TheStreet upgraded shares of VEON (NASDAQ:VEON) from a d+ rating to a c- rating in a research report report published on Thursday, TheStreetRatingsTable reports.

A number of other brokerages also recently commented on VEON. UBS Group downgraded shares of JinkoSolar from a buy rating to a neutral rating and increased their price objective for the company from $22.00 to $25.00 in a research report on Monday, June 17th. Bank of America reissued a buy rating and issued a $43.00 price objective (up from $36.00) on shares of The Medicines in a research report on Tuesday, July 9th. ValuEngine downgraded shares of Zynerba Pharmaceuticals from a buy rating to a hold rating in a research report on Tuesday, May 28th. Goldman Sachs Group raised shares of Altria Group from a neutral rating to a buy rating and set a $59.00 price objective on the stock in a research report on Thursday. Finally, BidaskClub downgraded shares of Vertex Pharmaceuticals from a buy rating to a hold rating in a research report on Tuesday, July 9th. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The stock currently has an average rating of Buy and a consensus target price of $3.19.

Shares of VEON opened at $3.17 on Thursday. VEON has a fifty-two week low of $2.07 and a fifty-two week high of $3.28. The business’s 50 day simple moving average is $2.61. The stock has a market cap of $5.62 billion, a P/E ratio of -13.78 and a beta of 1.81.

VEON (NASDAQ:VEON) last announced its earnings results on Thursday, May 2nd. The Wireless communications provider reported $0.08 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.02. VEON had a net margin of 10.00% and a negative return on equity of 17.37%. The firm had revenue of $2.12 billion for the quarter. On average, analysts anticipate that VEON will post 0.39 EPS for the current year.

A number of large investors have recently modified their holdings of VEON. Prosperity Capital Management Ltd acquired a new stake in VEON during the 1st quarter worth $93,487,000. Exor Investments UK LLP boosted its stake in VEON by 14.3% during the 1st quarter. Exor Investments UK LLP now owns 43,054,134 shares of the Wireless communications provider’s stock worth $89,983,000 after purchasing an additional 5,396,342 shares during the period. Segantii Capital Management Ltd acquired a new stake in VEON during the 1st quarter worth $10,450,000. Laurion Capital Management LP acquired a new stake in VEON during the 1st quarter worth $5,225,000. Finally, Acadian Asset Management LLC boosted its stake in VEON by 64.0% during the 1st quarter. Acadian Asset Management LLC now owns 5,765,425 shares of the Wireless communications provider’s stock worth $12,051,000 after purchasing an additional 2,250,828 shares during the period. Hedge funds and other institutional investors own 16.22% of the company’s stock.

VEON Company Profile

VEON Ltd., through its subsidiaries, provides mobile and fixed-line telecommunications services. It offers voice and data telecommunication services through a range of mobile and fixed-line technologies. The company provides value added services, including short messages, multimedia messages, caller number identification, call waiting, data transmission, mobile internet, downloadable content, mobile finance services, machine-to-machine, and other services; national and international roaming services; wireless Internet access and mobile financial services; and mobile bundles and call completion services.

Featured Article: What defines an oversold asset?

Analyst Recommendations for VEON (NASDAQ:VEON)

Receive News & Ratings for VEON Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VEON and related companies with MarketBeat.com's FREE daily email newsletter.